Details for New Drug Application (NDA): 011323
✉ Email this page to a colleague
NDA 011323 describes FUROXONE, which is a drug marketed by Shire and is included in two NDAs. Additional details are available on the FUROXONE profile page.
The generic ingredient in FUROXONE is furazolidone. There are three drug master file entries for this compound. Additional details are available on the furazolidone profile page.
The generic ingredient in FUROXONE is furazolidone. There are three drug master file entries for this compound. Additional details are available on the furazolidone profile page.
Summary for 011323
| Tradename: | FUROXONE |
| Applicant: | Shire |
| Ingredient: | furazolidone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011323
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 50MG/15ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
